Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone
about
Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone
description
2019 nî lūn-bûn
@nan
2019年の論文
@ja
2019年学术文章
@wuu
2019年学术文章
@zh
2019年学术文章
@zh-cn
2019年学术文章
@zh-hans
2019年学术文章
@zh-my
2019年学术文章
@zh-sg
2019年學術文章
@yue
2019年學術文章
@zh-hant
name
Primary treatment of light-cha ...... enalidomide, and dexamethasone
@en
type
label
Primary treatment of light-cha ...... enalidomide, and dexamethasone
@en
prefLabel
Primary treatment of light-cha ...... enalidomide, and dexamethasone
@en
P2093
P50
P1476
Primary treatment of light-cha ...... enalidomide, and dexamethasone
@en
P2093
Argyrios Ntalianis
Aristea-Maria Papanota
Asimina Papanikolaou
Despina Fotiou
Efstathios Kastritis
Efstathios Manios
Elektra Papadopoulou
Erasmia Psimenou
Evangelos Eleutherakis-Papaiakovou
Evangelos Terpos
P304
P356
10.1182/BLOODADVANCES.2019000147
P577
2019-10-01T00:00:00Z